Clinical Trial Update: Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for allogeneic γδ T cell therapy targeting malignant solid tumours, across Phase 1 and Phase 2, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Tumours

Drugs mentioned

• Allogeneic γδ T cell therapy

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Malignant Solid Tumours | Phase 1, Phase 2 | Status: UNKNOWN